Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibiotic Use in the First 2 Years of Life Is Related to Longitudinal BMI Trajectories From 0 to 18 years: A Prospective Cohort Study.

Journal of obesity·2026
Same author

Response: FIGO Preconception Checklist: Preconception care for mother and baby.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Designing and implementing a prediabetes screening in community pharmacies and online prevention program: findings from the PREDICT study.

BMC public health·2026
Same author

Not a Standalone Treatment: Considerations for Psychedelic-Assisted Therapy.

Brain and behavior·2026
Same author

Correlation of BMI With Potential Barriers to Mammographic Screening: Body Image, Pain, and Perceived Risk of Breast Cancer-A Cross-Sectional Study.

Journal of medical imaging and radiation oncology·2026
Same author

Early pregnancy biomarkers of inflammation and metabolic regulation in polycystic ovary syndrome.

The Journal of clinical endocrinology and metabolism·2026

Related Experiment Videos

Implementation salvage experiences from the Melbourne diabetes prevention study.

James Dunbar1, Andrea Hernan, Edward Janus

  • 1Greater Green Triangle University Department of Rural Health, Flinders University and Deakin University, Warrnambool, VIC 3280, Australia. director@greaterhealth.org

BMC Public Health
|September 21, 2012
PubMed
Summary

Implementing public health interventions like diabetes prevention programs can be challenging. This study details strategies used to overcome obstacles during a randomized controlled trial, offering valuable lessons for future research.

Related Experiment Videos

Area of Science:

  • Public Health
  • Implementation Science
  • Diabetes Prevention Research

Background:

  • Randomized controlled trials (RCTs) for public health interventions often face implementation challenges during scale-up.
  • The Melbourne Diabetes Prevention Study (MDPS) was nested within the state-wide Life! Taking Action on Diabetes program in Victoria, Australia.
  • This paper details the practical experiences and salvage strategies employed during the MDPS RCT.

Purpose of the Study:

  • To describe the implementation salvage experiences encountered during the Melbourne Diabetes Prevention Study.
  • To identify specific barriers and challenges faced during the RCT within a large-scale public health program.
  • To present the recovery strategies developed and applied by the study team.

Main Methods:

  • The study employed an implementation salvage strategies framework to conceptualize issues and recovery methods.
  • Documented specific challenges including funding continuity, program structural changes (eligibility, referral, content), and alternative delivery models.
  • Identified additional roadblocks such as staff turnover, recruitment difficulties, venue issues, participant availability, and participant characteristics.

Main Results:

  • Funding continuity and structural program changes significantly impacted trial execution.
  • Staff turnover, recruitment issues, and participant-related factors presented substantial evaluation roadblocks.
  • Each identified issue was addressed with specific salvage strategies, which are detailed in the paper.

Conclusions:

  • Conducting the Melbourne Diabetes Prevention Study provided invaluable experience for future trial execution.
  • Lessons learned will inform future RCTs and implementation research in public health.
  • Open sharing of barriers, challenges, and success factors in RCTs and implementation research is recommended to advance the field of implementation salvage.